Electrical Ventricular Remodeling in Dilated Cardiomyopathy
Christine Mages(MetLife (United States)), Dierk Thomas(Heidelberg University), Heike Gampp(Heidelberg University), Florian André(Heidelberg University), Pascal Syren(Heidelberg University), Norbert Frey(University Hospital Schleswig-Holstein), Patrick Lugenbiel(Heidelberg University), Ann‐Kathrin Rahm(Heidelberg University)
Cited by 20
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
|Circulation|2020|502
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction
|Cardiovascular Research|2014|316
Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
|Circulation|2015|195
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
|Experimental & Molecular Medicine|2013|172